Clinical Trial Update: Single Dose Ultibro Breezhaler by Sd-DPI Versus Ipratropium/Salbutamol by Nebulizer in COPD [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing a single dose of indacaterol/glycopyrronium via a dry-powder inhaler (Ultibro Breezhaler) with nebulized ipratropium/salbutamol in COP…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Ipratropium bromide and salbutamol (nebulized) (ipratropium bromide; salbutamol)
• Ultibro Breezhaler (indacaterol; glycopyrronium bromide)

Snippet

Sponsor: Wouter H. van Geffen | Conditions: COPD | Phase 4 | Status: COMPLETED